Learn how to safely transition between medications with professional medical guidance
Our findings confirm that longer diabetes duration is associated with a lower glycaemic response to GLP-1 RAs [3, 6, 16], probably due to declining beta cell function, as intact insulin secretion is necessary for a robust glycaemic response to this drug class [1, 3]
The trial included 529 patients from 13 countries in Europe, North America, South America and Asia
Below are some more articles to help you decide if GLP-1s are right for you
recalculate if your daily units differ
Other exclusion criteria included the use of any medication or nutritional supplement affecting sexual desire or arousal, uncontrolled hypertension (defined by specific blood pressure thresholds), recent changes in antihypertensive therapy, or other serious medical conditions [2]